Pituitary Adenomas: Understanding Prolactinomas and Hormone Imbalances

A prolactinoma is the most common type of pituitary adenoma - a benign tumor in the pituitary gland that overproduces the hormone prolactin. While many people have small pituitary tumors without ever knowing it, prolactinomas are different. They cause real, noticeable changes in your body because of the hormone chaos they create. In women, this often means missed periods, breast milk production even when not pregnant, and trouble getting pregnant. In men, it can lead to low libido, erectile dysfunction, and even breast enlargement. These aren’t rare side effects - they happen in over 90% of women and 80% of men with untreated prolactinomas.

What Exactly Is a Pituitary Adenoma?

The pituitary gland is a tiny pea-sized organ at the base of your brain. It’s often called the "master gland" because it controls other hormone-producing glands like the thyroid, adrenal glands, and ovaries or testes. When a tumor grows here - even if it’s not cancerous - it can mess with hormone signals in two ways: by making too much of one hormone, or by pressing on the gland and stopping it from making others.

About 1 in 10 people have some kind of pituitary growth, but only a small fraction cause symptoms. Prolactinomas make up 40% to 60% of all hormone-producing pituitary tumors. They’re classified by size: microadenomas are under 1 cm (about the size of a pea), and macroadenomas are larger than 1 cm. Macroadenomas are more likely to cause problems like vision loss because they can press on the optic nerve.

How Do Prolactinomas Disrupt Hormones?

Prolactin’s normal job is to help with breast milk production after childbirth. But when a tumor floods your system with extra prolactin, it throws off the whole hormone balance. High prolactin shuts down the signals that tell your ovaries or testes to make estrogen and testosterone. That’s why women stop menstruating and men lose sexual drive. It also lowers bone density over time, increasing fracture risk.

Doctors look for prolactin levels above 150 ng/mL - that’s 95% specific for a prolactinoma. Levels over 200 ng/mL almost always mean a macroadenoma. A simple blood test can catch this, but it’s not foolproof. Stress, pregnancy, kidney failure, and even certain medications can raise prolactin too. That’s why an MRI of the pituitary is always needed to confirm.

How Is It Diagnosed?

Diagnosis starts with a blood test for prolactin. If it’s high, the next step is a high-resolution MRI of the pituitary with 3mm slices. This shows the tumor’s size and whether it’s pushing into nearby structures. For tumors larger than 1 cm, doctors also check your vision with a visual field test. You might be asked to identify flashing lights in your peripheral vision - if you miss them, the tumor may be pressing on your optic nerves.

It’s important to rule out other causes of high prolactin. If you’re on antidepressants, antipsychotics, or even some stomach meds, those could be the culprit. Pregnancy and breastfeeding are obvious ones. But if none of those fit, and your MRI shows a tumor, it’s almost certainly a prolactinoma.

Treatment: Medication Is First

For almost all prolactinomas, the first treatment is a dopamine agonist - a drug that tricks the brain into thinking there’s enough prolactin already. The two main ones are cabergoline and bromocriptine. Cabergoline is now the go-to choice. It works better, has fewer side effects, and only needs to be taken once or twice a week. Bromocriptine requires daily doses and often causes nausea, dizziness, or low blood pressure.

Studies show cabergoline normalizes prolactin levels in 80-90% of microadenomas and about 70% of macroadenomas within three months. Tumor shrinkage happens in 85% of cases. One case from Mayo Clinic followed a woman with a 2.4 cm tumor and a prolactin level of 5,200 ng/mL. After six months on cabergoline, her levels dropped to 18 ng/mL and the tumor shrank by 70%.

Most people start with 0.25 mg twice a week. The dose is slowly increased every few weeks based on blood tests. Side effects like nausea or lightheadedness usually fade after a few weeks. If they don’t, lowering the dose temporarily helps. A small number of people (about 2-7%) on long-term, high-dose cabergoline (over 2 mg per week) may develop heart valve issues. That’s why doctors recommend an echocardiogram after one year of treatment.

When Is Surgery Needed?

Surgery isn’t the first option - but it’s life-changing for some. Transsphenoidal surgery means removing the tumor through the nose. It’s minimally invasive, leaves no facial scars, and most patients go home in 3-5 days. Success rates are high for small tumors: 85-90% of microadenomas are fully removed. But for macroadenomas, especially those that have grown into the cavernous sinus (where major blood vessels sit), success drops to 35-50%.

Doctors usually recommend surgery if:

• Medication doesn’t work or causes unbearable side effects
• The tumor is pressing on the optic nerve and threatening vision
• The patient wants to get pregnant and can’t tolerate long-term drugs

Still, surgery has risks. About 5-10% of patients develop diabetes insipidus - a condition where the body can’t hold water - and need daily desmopressin. CSF leaks (fluid from the brain) happen in 2-5% of cases. And in about 1-2% of cases, sudden bleeding into the tumor (pituitary apoplexy) requires emergency surgery.

Radiation Therapy: A Last Resort

Radiation is rarely used today, mostly for tumors that won’t shrink with meds or surgery. Options include Gamma Knife radiosurgery (one high-dose session), conventional radiation (given daily over weeks), or proton therapy.

Gamma Knife controls tumor growth in 95% of cases after five years and causes less damage to surrounding tissue than older radiation methods. But it doesn’t fix hormone problems fast. It can take 2-5 years for prolactin levels to drop. And about 30-50% of patients end up with low levels of other pituitary hormones (hypopituitarism) within 10 years - meaning they’ll need lifelong hormone replacement.

Most patients who get radiation say they still felt symptoms for over a year. But by year three, 85% saw improvement. It’s slow, but it works when nothing else does.

Life After Diagnosis

Many people worry about lifelong medication. But here’s the truth: over 70% of people with prolactinomas need to stay on dopamine agonists indefinitely. Stopping the drug, even for a few days, can cause prolactin to spike again within 72 hours. That’s why consistency matters.

Monitoring is key. Blood tests every three months at first, then once a year if things are stable. MRIs every one to two years. Vision checks if you had a large tumor. And if you’re on cabergoline long-term, get your heart checked every two years.

Women who want to get pregnant can often stop medication under supervision. Prolactin levels usually drop naturally during pregnancy, and the tumor rarely grows. But close monitoring is still needed.

For men, restoring testosterone levels often brings back energy, mood, and sex drive. Bone density improves with treatment, reducing fracture risk.

What’s Coming Next?

New drugs are on the horizon. A medication called paltusotine, already approved for acromegaly, is being tested for prolactinomas. It might offer better control with fewer side effects. Researchers are also looking at gene therapy - using CRISPR to fix mutations linked to tumor growth. AI is helping surgeons plan more precise removals by mapping tumor boundaries in 3D.

But for now, the best approach remains simple: catch it early, treat with cabergoline, and stick with it. Most people go on to live full, healthy lives - with normal hormone levels, fertility, and no major complications.